Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke

Cesario V. Borlongan, Guolong Yu, Noriyuki Matsukawa, Lin Xu, David C Hess, Paul R. Sanberg, Yun Wang

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The present study examined the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats were initially subjected to transient middle cerebral artery occlusion (MCAo) then randomly assigned to one of the following treatment conditions: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle exhibited significant cognitive impairments, as revealed by passive avoidance and Morris water maze tasks, at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal cognitive performance throughout the test period. Ischemic animals that received low dose CsA plus MP also showed significantly less cognitive deficits but such attenuation of stroke-induced behavioral impairments was only consistently reflected in the passive avoidance task, while performance in the Morris water maze task deteriorated over time. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. These observations suggest that despite overt cerebral damage, alterations in simple, but not complex, cognitive tasks produced by MCAo could be ameliorated by low dose CsA when combined with MP.

Original languageEnglish (US)
Pages (from-to)1503-1512
Number of pages10
JournalLife sciences
Volume76
Issue number13
DOIs
StatePublished - Feb 11 2005

Fingerprint

Methylprednisolone
Cyclosporine
Rats
Stroke
Animals
Middle Cerebral Artery Infarction
Water
Task Performance and Analysis
Neuroprotective Agents
Immunosuppressive Agents
Sprague Dawley Rats
Anti-Inflammatory Agents

Keywords

  • Brain infarct
  • Cerebral ischemia
  • Cognitive tasks
  • Immunosuppression
  • Inflammation
  • Neuroprotection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke. / Borlongan, Cesario V.; Yu, Guolong; Matsukawa, Noriyuki; Xu, Lin; Hess, David C; Sanberg, Paul R.; Wang, Yun.

In: Life sciences, Vol. 76, No. 13, 11.02.2005, p. 1503-1512.

Research output: Contribution to journalArticle

Borlongan, Cesario V. ; Yu, Guolong ; Matsukawa, Noriyuki ; Xu, Lin ; Hess, David C ; Sanberg, Paul R. ; Wang, Yun. / Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke. In: Life sciences. 2005 ; Vol. 76, No. 13. pp. 1503-1512.
@article{0e757ff65a2e4d4caef5037cd3b7991b,
title = "Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke",
abstract = "The present study examined the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats were initially subjected to transient middle cerebral artery occlusion (MCAo) then randomly assigned to one of the following treatment conditions: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle exhibited significant cognitive impairments, as revealed by passive avoidance and Morris water maze tasks, at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal cognitive performance throughout the test period. Ischemic animals that received low dose CsA plus MP also showed significantly less cognitive deficits but such attenuation of stroke-induced behavioral impairments was only consistently reflected in the passive avoidance task, while performance in the Morris water maze task deteriorated over time. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. These observations suggest that despite overt cerebral damage, alterations in simple, but not complex, cognitive tasks produced by MCAo could be ameliorated by low dose CsA when combined with MP.",
keywords = "Brain infarct, Cerebral ischemia, Cognitive tasks, Immunosuppression, Inflammation, Neuroprotection",
author = "Borlongan, {Cesario V.} and Guolong Yu and Noriyuki Matsukawa and Lin Xu and Hess, {David C} and Sanberg, {Paul R.} and Yun Wang",
year = "2005",
month = "2",
day = "11",
doi = "10.1016/j.lfs.2004.09.022",
language = "English (US)",
volume = "76",
pages = "1503--1512",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke

AU - Borlongan, Cesario V.

AU - Yu, Guolong

AU - Matsukawa, Noriyuki

AU - Xu, Lin

AU - Hess, David C

AU - Sanberg, Paul R.

AU - Wang, Yun

PY - 2005/2/11

Y1 - 2005/2/11

N2 - The present study examined the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats were initially subjected to transient middle cerebral artery occlusion (MCAo) then randomly assigned to one of the following treatment conditions: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle exhibited significant cognitive impairments, as revealed by passive avoidance and Morris water maze tasks, at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal cognitive performance throughout the test period. Ischemic animals that received low dose CsA plus MP also showed significantly less cognitive deficits but such attenuation of stroke-induced behavioral impairments was only consistently reflected in the passive avoidance task, while performance in the Morris water maze task deteriorated over time. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. These observations suggest that despite overt cerebral damage, alterations in simple, but not complex, cognitive tasks produced by MCAo could be ameliorated by low dose CsA when combined with MP.

AB - The present study examined the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats were initially subjected to transient middle cerebral artery occlusion (MCAo) then randomly assigned to one of the following treatment conditions: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle exhibited significant cognitive impairments, as revealed by passive avoidance and Morris water maze tasks, at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal cognitive performance throughout the test period. Ischemic animals that received low dose CsA plus MP also showed significantly less cognitive deficits but such attenuation of stroke-induced behavioral impairments was only consistently reflected in the passive avoidance task, while performance in the Morris water maze task deteriorated over time. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. These observations suggest that despite overt cerebral damage, alterations in simple, but not complex, cognitive tasks produced by MCAo could be ameliorated by low dose CsA when combined with MP.

KW - Brain infarct

KW - Cerebral ischemia

KW - Cognitive tasks

KW - Immunosuppression

KW - Inflammation

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=12844262878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12844262878&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2004.09.022

DO - 10.1016/j.lfs.2004.09.022

M3 - Article

C2 - 15680314

AN - SCOPUS:12844262878

VL - 76

SP - 1503

EP - 1512

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 13

ER -